Sensei Biotherapeutics, Inc. Net Income Loss

• Sensei Biotherapeutics, Inc. showed an increase of +30.1% in Net Income Loss from 2024 to 2025.
• This data is from Sensei Biotherapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
• XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 6 years of available data (2020 to 2025), Sensei Biotherapeutics, Inc.'s Net Income Loss has declined by 4.9%.
• Historical annual values: Fiscal year 2025: -$21.09 million | Fiscal year 2024: -$30.16 million | Fiscal year 2023: -$34.10 million | Fiscal year 2022: -$48.59 million | Fiscal year 2021: -$36.79 million | Fiscal year 2020: -$20.10 million.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026